INTRODUCTION
Similarly to other cancer patients, head and neck cancer (HNC) patients with nonprivate insurance, Medicaid insurance, or no insurance have been shown to have treatment delays 1 and inferior survival outcomes [1] [2] [3] [4] in comparison with patients with private insurance. These associations exist independently of sex, age, race, smoking status, alcohol use, tumor site, socioeconomic status, and treatment. 4 Insurance-associated disparities at the initial presentation have been shown for laryngeal patients, 5, 6 oropharyngeal patients, 7 and HNC patients overall. 1, 8 Although this advanced tumor stage at presentation among cancer patients, including HNC patients, with nonprivate, Medicaid, or no insurance 1, 4, 5, 7 might contribute to suboptimal outcomes among patients with these insurance types, critically, studies continue to show tumor outcome disparities associated with the insurance status, even after controlling for the cancer stage at the time of diagnosis. 2, 4 Recently, it has been suggested that quality differences in the hospitals where care is provided might underlie this observed disparity. Although having insurance coverage helps to mitigate the effect of social determinants of health on cancer-related mortality, it fails to completely account for the disparities. 9 In fact, the finding that insured people from advantaged communities have superior outcomes in comparison with insured patients from disadvantaged communities could be attributable to advantaged communities having access to better hospitals, 9 whereas uninsured and Medicaid patients may access lower quality care. 10 Besides the genetic differences, health care system factors related to unequal access have been suggested to be the predominant reasons for significant variations in care, despite comparable insurance statuses, incomes, ages, or disease severity. 11 Despite these suggestions, there have been few studies of HNC patients that have directly investigated the relation between the insurance coverage type and hospital selection. Al-Refaie et al 12 found that the insurance type predicted the likelihood of undergoing surgery at lowvolume hospitals for lung cancer patients. Compared with patients with private insurance, those with Medicaid, Medicare, or other insurance types and self-payers were more likely to be treated surgically at a low-volume hospital.
In the current study, we asked whether the type of hospital providing care for HNC patients was related to their insurance type. In accordance with suggestions about the possible role of differential access to quality care in determining insurance-based differences in outcomes, we hypothesized that patients with Medicaid, Medicare, or no insurance would be more likely to visit hospitals associated with poor cancer outcomes.
MATERIALS AND METHODS

Data Set and Patient Selection
The National Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) is the nation's largest all-payer inpatient database. 13 When weighted to the level of the US population, it contains administrative discharge data on approximately 35 million hospitalizations nationwide each year. 13 All patients in the NIS from 2012 and 2013 with an International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code for HNC who were 18 years old or older were included in the sample. Specifically, we included the following International Classification of Diseases, Ninth Revision diagnosis codes: laryngeal cancer; carcinomas of the mobile tongue, gingiva, floor of the mouth, cheek mucosa, mouth vestibule, palate region, retromolar region, lips, base of the tongue, other unspecified part of oral cavity and pharynx, oropharynx, hypopharynx, nasopharynx, nasal cavity, paranasal sinuses, and salivary glands; and head and neck metastases from an unknown primary.
Exposure and Outcomes
The primary exposure was the type of insurance coverage for each patient undergoing care for HNC (private, Medicare, Medicaid, or no/other insurance type). The primary outcome measures were the hospital location and teaching status (urban teaching, urban nonteaching, or rural) and the hospital ownership status (private nonprofit, government [nonfederal], or private investor-owned).
Covariates
The following patient-level factors were observed and incorporated into multivariate analyses as appropriate: age (26, >26 to <65, or 65 years), race/ethnicity (white, black, Hispanic, or other [Asian, Pacific Islander, Native American, and unknown]), sex (male vs female), number of comorbidities (based on the Charlson comorbidity index score), median household income (based on the national quartiles for the patient's zip code), mortality risk score, and geographic location of residence (based on the National Center for Health Statistics urban-rural classification scheme). The mortality risk was based on the All Patient Refined-Diagnosis Related Group mortality risk score. This score adjusts for the interactions between a patient's primary diagnosis, secondary diagnosis, age, and procedures occurring during hospitalization. On the basis of these factors, 4 subclasses are defined as 1) minor, 2) moderate, 3) major, and 4) extreme. 14 The geographic location of patients was categorized as metropolitan (all metro areas) or nonmetropolitan (micropolitan, not metropolitan).
Statistical Analysis
Pearson chi-square tests and Kruskal-Wallis nonparametric tests were used to evaluate differences across insurance categories for categorical and continuous data, respectively. Multivariate multinomial logistic regression models were constructed to determine the association between the hospital location and teaching status and the hospital ownership status across the insurance categories. All statistical tests were 2-sided with a set at .05. We also performed a sensitivity analysis to account for multiple comparisons by computing the adjusted P values for the primary exposure variable (insurance status categories) with Hommel's method. 15, 16 Analyses were performed with Stata MP version 14 (StataCorp, College Station, Texas). With methods recommended by HCUP, 13 data were weighted to provide approximations at the level of the US population. The study was determined to be exempt by the institutional review board at Partners HealthCare.
RESULTS
Patient and Hospital Characteristics
A total of 37,466 patient visits to hospitals were recorded for HNC in 2012 (50.5%) and 2013 (49.5%), and they represented 187,330 visits at the US national population level. The median age of the patients was 62 years (interquartile range, 54-71 years). A total of 46.0% were covered by Medicare, 15.8% were covered by Medicaid, 30.6% were covered by private insurers, and 7.6% either were uninsured or had another payment method. In all, 67.5% of the patients were male, and 53.8% were classified as being in the lower 2 quartiles for annual income. Among those for whom race/ethnicity was reported (94.4%), 73.3% were white, and 12.8% were black. All patients had 2 or more comorbidities according to the Charlson comorbidity index, and 78.0% of the patients were classified as being at either moderate or major risk of in-hospital mortality, with an additional 7.5% classified as being at extreme risk. The majority of the patients underwent care at private nonprofit hospitals (73.0%) and urban teaching hospitals (68.81%; Table 1 ).
Associations With the Hospital Location and Teaching Status
After adjustments for the sex, income, age, mortality risk, and race/ethnicity of the patients, we found that compared with those with private insurance, patients with Medicare (odds ratio [OR], 1.61; 95% confidence interval [CI], 1.40-1.86; P < .001), patients with Medicaid (OR, 1.32; 95% CI, 1.14-1.54; P < .001), and patients with no/other insurance (OR, 1.30; 95% CI, 1.08-1.57; P 5 .007) were significantly more likely to seek care at rural hospitals than urban teaching hospitals. Medicare (OR, 1.23; 95% CI, 1.14-1.33; P < .001) and uninsured/ other insurance patients (OR, 1.14; 95% CI, 1.03-1.27; P 5 .012) were also more likely than private insurance holders to seek care at urban nonteaching hospitals versus urban teaching hospitals (Table 2) .
Associations With the Hospital Control Status
Compared with private insurance holders, after adjustments for the aforementioned factors, Medicare (OR, 1.16; 95% CI, 1.03-1.30; P 5 .010) and uninsured/other insurance holders (OR, 1.43; 95% CI, 1.23-1.67; P < .001) were more likely to seek care at a private investor-owned for-profit hospital than a private nonprofit hospital. Medicaid (OR, 1.51; 95% CI, 1.39-1.64; P < .001) and uninsured/other insurance holders (OR, 2.29; 95% CI, 2.07-2.53; P < .001) were also more likely Original Article to visit a government (nonfederal) hospital versus a private nonprofit hospital (Table 3) .
Sensitivity Analysis
Adjusting for the geographic location
The geographic location was missing for 50.8% of the index hospitalizations. An additional adjustment for location in the multivariate models demonstrated similar findings. Nonprivate insurance types continued to be associated with increased odds of visiting rural or urban nonteaching or private investor-owned or government (nonfederal) hospitals (Tables 4 and 5 ).
Recategorization of age
To account for an increased prevalence of HNC in those older than 45 years, multivariate models, adjusted with the age categorized as 26; > 26 to 45; > 45 to < 65; and 65 demonstrated similar findings. Nonprivate insurance types continued to be associated with increased odds of visiting rural or urban nonteaching or private investor-owned or government (nonfederal) hospitals.
DISCUSSION
Better outcomes for several conditions, including HNC, have been demonstrated in urban hospitals versus rural hospitals, 17 in academic teaching hospitals versus nonteaching hospitals, [18] [19] [20] [21] [22] [23] and in not-for-profit hospitals versus for-profit or government hospitals. 17, 18, [24] [25] [26] To explain the disparities in patients' outcomes related to their insurance types, we hypothesized that compared with privately insured patients, patients with nonprivate insurance types would be more likely to receive care at hospitals showing poor outcomes. Findings from our study supported this hypothesis. We found that HNC patients with Medicaid, Medicare, or no insurance were more likely to be admitted to rural, urban nonteaching, government (nonfederal), or private investor-owned forprofit hospitals than patients who had private insurance. With an additional adjustment for patients' geographic locations, patients with Medicaid, Medicare, or no insurance continued to be more likely to visit at least 1 hospital type associated with poor outcomes independently of age, sex, race/ethnicity, income status, and mortality risk score. Differences in outcomes based on inpatient treatment settings are well established. Consequently, factors that affect where a patient receives care are likely to influence the outcome. According to previous studies and the literature, the reasons for suboptimal outcomes in certain hospital settings are likely to be multifactorial and include differences in staffing levels and skills [27] [28] [29] [30] [31] ; in resources, services, infrastructure, technologies, and available equipment 23, [30] [31] [32] ; in experience driven by the patient volume 30, 33 ; in compliance with treatment guidelines 34 ; and in postoperative complication management. 23, 32 In contrast to our findings of significant differences between urban teaching, nonteaching, and rural hospitals by insurance status, Bhattacharyya et al 31 analyzed data from the NIS and did not find any significant difference in the distribution of HNC patients by insurance status (payer mix) in teaching hospitals versus nonteaching hospitals in 2010. These differences might be the result of the different categorization of a hospital's teaching status in this study. They examined differences in teaching hospitals versus nonteaching hospitals; this was discontinued in the NIS after 2011 when HCUP instead combined the hospital's urban/rural and teaching/nonteaching designations to report the composite variable used in our study. Also, although their results did not reach statistical significance, they found a higher proportion of privately insured and Medicaid patients seeking care at teaching hospitals and a higher proportion of Medicare patients visiting nonteaching hospitals. 31 They also pointed out that future studies would be needed to determine whether this "lack of maldistribution of payers" in teaching hospitals versus nonteaching hospitals would continue to persist with rising numbers of human papillomavirus-related HNC cases. 31 HNC patients frequently have numerous risk factors, such as advanced age, a history of tobacco or alcohol consumption, and cardiopulmonary disorders, that can complicate their perioperative care. With these complications, they require more complex care and thus pose an increased burden on the health care system. These patients consume more hospital and physician resources than patients who undergo other otolaryngological surgeries. 35 Several studies have shown differences in HNC patient outcomes based on hospital characteristics. The P value remained significant at the level of <.05 after we had accounted for multiple comparisons with Hommel's method of adjustment for the 3 categories of the primary exposure of interest (insurance type).
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Eskander et al 36 concluded that a volume-outcome relation exists for HNCs, with high-volume hospitals having better overall survival than low-volume hospitals. They suggested that for complex procedures such as HNC resections, for which an extended hospital length of stay along with a multidisciplinary team delivering care is required, the hospital volume is a stronger determinant of the outcomes than the surgeon volume. Safety-net hospitals, which often treat patients with higher comorbidity and are more likely to be teaching hospitals, show no difference in mortality from non-safety-net hospitals. However, at low-volume hospitals, which are often nonteaching hospitals, outcomes are inferior. 37 These findings for HNC patients along with similar findings for other procedures have increased interest in exploring the possibility of regionalizing the procedures to improve patient outcomes. 38, 39 The Centers for Medicare and Medicaid Services has designated some hospitals as centers of excellence on the basis of data indicating improved outcomes. 40 Recent data indicate an increasing regionalization of HNC care to teaching and academic hospitals. 31 However, the findings from our study raise a question about equitable access: do patients with all insurance types have an equal opportunity to undergo treatment at these highperformance centers? Bhattacharyya et al 37 found that although the payer status mix did not change from 2000 to 2005 to 2010 in teaching hospitals, the proportion of total patients with HNC who were covered by Medicaid increased significantly in nonteaching hospitals over those years. Although more HNC cases are being seen at teaching hospitals, 31 these findings underscore the importance of evaluating the characteristics of patient populations to maximize the benefits of regionalization of care. This will also necessitate an examination of the underlying factors that might be inhibiting patients with certain insurance types from seeking care at these centers of excellence. Ensuring adequate access to care is a key factor in reducing health disparities, which is also the overarching goal of the Healthy People 2020 initiative. 41 If such barriers are not addressed simultaneously, regionalization might in reality further compromise the patient outcomes by limiting timely access to high-quality care for Medicaid, Medicare, or uninsured patients. 31 Another significant finding from our study is the impact of the geographic location of patients. Even after we had controlled for the residential status (metropolitan vs micropolitan), the patients with nonprivate insurance were more likely to be treated at a hospital type associated with poor outcomes. However, some of the associations between the insurance status type and the hospital setting lost statistical significance after we had controlled for the National Center for Health Statistics urban-rural designation. We could not account for the geographic distance between a patient's primary residence and the hospital of care, so future studies might be needed to improve our understanding of the potential role of geographical barriers. Our understanding will also benefit from future studies examining other factors influencing inequitable access to types of hospital facilities across different insurance categories, such as the insurance acceptance policies of hospitals. It will also be important to study how these disparities in access to care affect outcomes independently of the cancer stage, cancer site, treatment modality, and coexisting morbidities.
Our study has certain limitations. We were not able to account for repeat visits by a patient because the NIS reports data from each index hospitalization. This limited our ability to account for clustering effects for visits by the same patient and to assess whether the choice of hospital or insurance type changed with subsequent visits. We also could not account for the complexity of HNC or the cancer site. Our results are subject to the accuracy of the coding in the database. 42 Because of the categorization of the variables controlled for in the analysis and other confounders that were not assessed in this analysis, there is a probability of residual confounding. The P value remained significant at the level of <.05 after we had accounted for multiple comparisons with Hommel's method of adjustment for the 3 categories of the primary exposure of interest (insurance type).
